Download image 5.33 MB · Contacts · Careers · Healthcare professionals · Liberate Life. Follow us. Linkedin · Cookie policy · Privacy notice · Website terms ...

4 მაი. 2024 · Says Oelkers has extensive experience from pharmaceutical and health care companies including a role as President and CEO of the Swedish ...

Guido Oelkers is a businessperson who has been at the helm of 8 different companies. Dr. Oelkers is President & Chief Executive Officer for Swedish Orphan ...

Guido Oelkers is Chief Executive Officer at Swedish Orphan Biovitrum AB. See Guido Oelkers's compensation, career history, education, & memberships.

Guido Oelkers, Ph.D., is the Chief Executive Officer of Swedish Orphan Biovitrum since 2017. Prior to that, he worked for BSN medical.

4 მაი. 2017 · Guido Oelkers was born in 1965 and holds a PhD in Strategic Management from the University of South Australia and a Master of Economics from ...

1 აგვ. 2024 · The CEO & President, Guido Oelkers, recently sold a substantial kr59m worth of stock at a price of kr293 per share. That sale reduced their total holding by 38 ...

15 აპრ. 2017 · Guido Oelkers was born in 1965 and holds a PhD in Strategic Management from the University of South Australia and a Master of Economics from ...

News stories and articles referencing Guido Oelkers on European Pharmaceutical Review.

22 ივნ. 2017 · Rare disease drug developer Swedish Orphan Biovitrum AB (Sobi) has named Guido Oelkers as the company's new President and CEO.